Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Content zoeken bij Prinses Máxima Centrum
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Overall survival and PD-L1 expression in metastasized malignant melanoma
Jules Gadiot
, Anna I. Hooijkaas
, Andrew D.M. Kaiser
,
Harm Van Tinteren
, Hester Van Boven
, Christian Blank
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel
›
peer review
214
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Overall survival and PD-L1 expression in metastasized malignant melanoma'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Overall Survival
100%
Metastasizing
100%
Malignant Melanoma
100%
PD-L1 Expression
100%
Transforming Growth Factor-β
33%
Programmed Death-ligand 1 (PD-L1)
33%
Melanoma Patients
33%
Primary Melanoma
33%
Immunologic Factors
33%
Tumor
16%
Netherlands
16%
Patient Cohort
16%
Metastatic Disease
16%
Prognostic Relevance
16%
CD8+ T Cells
16%
Distant Metastasis
16%
Regulatory T Cells
16%
Patient Survival
16%
Disease Progression
16%
Prognostic Marker
16%
Negative Association
16%
Immune System
16%
Longitudinal Analysis
16%
Systemic Therapy
16%
Inhibitory Receptors
16%
CD4 T Cells
16%
Lymph Node
16%
MHC Class II
16%
Paraffin Embedding
16%
Conflicting Results
16%
Sentinel Node Procedure
16%
Breslow Thickness
16%
Impact on Patients
16%
Stage III-IV
16%
Melanoma Cells
16%
Nevus
16%
T Cell Infiltration
16%
B7-H1
16%
Antibody Verification
16%
Tumor Immune Escape
16%
In-transit
16%
Cancer Institute
16%
Medicine and Dentistry
Overall Survival
100%
Programmed Death-Ligand 1
100%
Melanoma
100%
Malignant Neoplasm
25%
Neoplasm
25%
Metastatic Carcinoma
25%
Transforming Growth Factor Beta
25%
T Cell
12%
Systemic Therapy
12%
Cytotoxic T-Cell
12%
Upregulation
12%
Cellular Infiltration
12%
Programmed Cell Death
12%
Receptor
12%
Regulatory T Cell
12%
T-Helper Cell
12%
Clinical Study
12%
Disease Exacerbation
12%
Immune System
12%
Secretion (Process)
12%
Lymph Node
12%
Sentinel Node
12%
Melanoma Cell
12%
Immunity
12%
Nevus
12%
Immunology and Microbiology
Overall Survival
100%
Programmed Death-Ligand 1
100%
Transforming Growth Factor Beta
25%
T Cell
12%
Immune Escape
12%
Cell Death
12%
Cell Infiltration
12%
Secretion (Process)
12%
Regulatory T Cell
12%
Lymph Node
12%
Upregulation
12%
Immune System
12%
Melanoma Cell
12%
CD4
12%
CD8
12%
Immunology
12%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
PD-L1
100%
Transforming Growth Factor Beta
25%
Immunity
25%
T Cell
12%
CD8
12%
Cell Death
12%
Upregulation
12%
Secretion (Process)
12%
Regulatory T Cell
12%
Clinical Study
12%
CD4
12%
Cell Infiltration
12%